FDA-Drug2026-10-14Class IIPROCESSING DEFECT

Carolina Infusion Tri-MIX injectable recalled for sterility assurance issue

OTHERNationwide distributionDrugs

What this means

Carolina Infusion LLC is recalling Tri-MIX (papaverine/phentolamine/alprostadil) injectable solution due to concerns that processing equipment may not have maintained proper sterility standards during manufacturing. The product is a compounded injectable medication packaged in single-use syringes for individual patient prescriptions.

  • If you have received this medication, contact your healthcare provider or pharmacist immediately
  • Do not use the product; return it to the pharmacy where it was dispensed
  • Check your prescription records for lot 08062026@10 with a beyond-use date of 9/20/2026
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Lack of Assurance of Sterility: Related to processing equipment used in compounded product.

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
5 mL in patient specific syringe dose
Manufactured in
95 Bees Creek Rd, N/A, Ridgeland, SC, United States
Products
Tri-MIX (PAPAV/PHENTO/ALPROS),30/1/60, injectable, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0025-2027

More Carolina Infusion recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.